Cargando…
Defining the level of evidence for technology adoption in the localized prostate cancer pathway
New technologies in prostate cancer are attempting to change the current prostate cancer pathway by aiming to reduce harms while maintaining the benefits associated with screening, diagnosis, and treatment. In this article, we discuss the optimal evaluation that new technologies should undergo to pr...
Autores principales: | Valerio, Massimo, El-Shater Bosaily, Ahmed, Emberton, Mark, Ahmed, Hashim U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136740/ https://www.ncbi.nlm.nih.gov/pubmed/24332638 http://dx.doi.org/10.1016/j.urolonc.2013.10.008 |
Ejemplares similares
-
The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update
por: El-Shater Bosaily, Ahmed, et al.
Publicado: (2015) -
PROMIS — Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer()
por: El-Shater Bosaily, A., et al.
Publicado: (2015) -
Erratum: The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial
por: El-Shater Bosaily, A, et al.
Publicado: (2016) -
The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial
por: El-Shater Bosaily, A, et al.
Publicado: (2016) -
Le déficit immunitaire humoral: mieux le connaître pour mieux le prendre en charge
por: El Bakkouri, Jalila, et al.
Publicado: (2014)